TotalMarketCap

Enliven Therapeutics

ELVNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.277 B

$44.73 -5.33%

Close of 6 Nov 2026

As of 6 Nov 2026, Enliven Therapeutics (ELVN) has a market capitalization of $3.28B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$103.7M

Loss-making

Shares outstanding

73,595,132

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #69Parabilis MedicinesPBLS$3.41B
  2. #70Viking TherapeuticsVKTX$3.29B
  3. #71Enliven TherapeuticsELVN$3.28B
  4. #72Dyne TherapeuticsDYN$3.25B
  5. #73Viridian TherapeuticsVRDN$3.24B

What if Enliven Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$385,377.11

Per share 8,616× higher

Bitcoin $1.53T

$20,852.08

Per share 466× higher

Apple $5.02T

$68,455.45

Per share 1,530× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Enliven Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.